FRIDAY, MAY 17, 2024 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab (Imdelltra) is only for patients who have exhausted all other options to treat extensive-stage small cell lung cancer.Continue Reading

FRIDAY, May 17, 2024 (HealthDay News) — Cutting-edge cancer treatments are essentially useless for patients barely clinging to life, a new study shows. Chemotherapies, immunotherapies, targeted therapies and hormone therapies do not improve survival rates in patients with very advanced tumors near the end of life, according to findings publishedContinue Reading

THURSDAY, May 16, 2024 (HealthDay News) — For anyone newly diagnosed with blood cancers known as lymphomas, their first question might be: What treatments can help? Of course, there have been big advances in chemotherapy against the disease, but treatments now go beyond chemo, said Mayo Clinic expert Dr. StephenContinue Reading